Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation-Reference-Cited by-同舟云学术

Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation

Published:2021-01-26 Issue:4 Volume:15 Page:1130-1145
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Zhao Xiaoliang¹²,Kim In‐Kyu¹³^ORCID,Kallakury Bhaskar¹,Chahine Joeffrey J.¹,Iwama Eiji¹,Pierobon Mariaelena⁴,Petricoin Emanuel⁴,McCutcheon Justine N.¹,Zhang Yu‐Wen¹,Umemura Shigeki¹,Chen Vincent¹,Wang Changli²^ORCID,Giaccone Giuseppe¹

Affiliation:

1. Lombardi Comprehensive Cancer Center Georgetown University Washington DC USA

2. Department of Lung Cancer Tianjin Key Laboratory of Cancer Prevention and Therapy National Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital China

3. Department of Surgery Open NBI Convergence Technology Research Laboratory Yonsei Cancer Center Severance Hospital Yonsei University College of Medicine Seoul South Korea

4. George Mason University Manassas VA USA

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12882

Reference50 articles.

1. Comprehensive genomic profiles of small cell lung cancer

2. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

3. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR

4. Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities

5. The DNA damage response: putting checkpoints in perspective

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AZD1775 synergizes with SLC7A11 inhibition to promote ferroptosis;Science China Life Sciences;2024-09-06

2. The Role of ADCY1 in Regulating the Sensitivity of Platinum-Based Chemotherapy in NSCLC;Pharmaceuticals;2024-08-24

3. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

4. The Role of Transglutaminase 2 in Cancer: An Update;International Journal of Molecular Sciences;2024-02-28

5. Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities;Cancers;2024-02-27